Abstract:Photodynamic therapy (PDT) using two-photon near-infrared light excitation is a very effective way to avoid the use of short-wavelength ultraviolet or visible light which cannot efficiently penetrate into the biological tissues and is harmful to the healthy cells. Herein, a series of cyclometalated Ir(III) complexes with a structurally simple diimine ligand were designed and the synthetic route and preparation procedure were optimized, so that the complexes could be obtained in apparently higher yield, productivity, and efficiency in comparison to the traditional methods. Their ground state and excited singlet and triplet state properties were studied by spectroscopy and quantum chemistry theoretical calculations to investigate the effect of substituent groups on the photophysical properties of the complexes. The Ir(III) complexes, especially Ir1 and Ir3, showed very low dark toxicities and high phototoxicities under both one-photon and two-photon excitation, indicating their great potential as PDT agents. They were also found to be highly sensitive two-photon mitochondria dyes.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.inorgchem.0c01509?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.inorgchem.0c01509</a>.Optimized structures and frontier molecular orbitals, simulated and experimental electronic absorption spectra, cyclic voltammetry, emission spectra in aqueous solution, time-dependent changes in absorption spectra of DPBF in the presence of Ir(III) complexes, Pearson's correlation coefficient (R) analysis (PCCA) between Ir(III) complexes and MTG by CLSM on human cancer cells A549, Z-stack images of A549 stained by Ir(III) complexes, DNA-binding experiments, and experimental and computational absorption spectral data and Cartesian coordinates of the optimized structures of Ir(III) complexes for S0, S1, and T1 states (<a class="ext-link" href="/doi/suppl/10.1021/acs.inorgchem.0c01509/suppl_file/ic0c01509_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Mitochondrial‐DNA‐Targeted IrIII‐Containing Metallohelices with Tunable Photodynamic Therapy Efficacy in Cancer Cells

Cyclometalated Ir(III) Complexes as Mitochondria-Targeted Photodynamic Anticancer Agents

Synthesis, Photophysical and Anticancer Properties of Mitochondria-Targeted Phosphorescent Cyclometalated Iridium(iii) N-heterocyclic Carbene Complexes.

Enhanced cancer therapy by the marriage of metabolic alteration and mitochondrial-targeted photodynamic therapy using cyclometalated Ir(iii) complexes.

Lighting up metallohelices: from DNA binders to chemotherapy and photodynamic therapy

Cyclometalated iridium(iii) complex nanoparticles for mitochondria-targeted photodynamic therapy

Lighting Up Metallohelices: from DNA Binders to Chemotherapy and Photodynamic Therapy.

Cyclometalated iridium(III) tetrazine complexes for mitochondria-targeted two-photon photodynamic therapy

A Mitochondria Targeting Ir(III) Complex Triggers Ferroptosis and Autophagy for Cancer Therapy: A Case of Aggregation Enhanced PDT Strategy for Metal Complexes

Phosphorescent Iridium(iii)-Bis-n-heterocyclic Carbene Complexes As Mitochondria-Targeted Theranostic and Photodynamic Anticancer Agents.

A Mitochondria-Targeted Iridium(iii)-Based Photoacid Generator Induces Dual-Mode Photodynamic Damage Within Cancer Cells

An Iridium(iii)-Palladium(ii) Metal-Organic Cage for Efficient Mitochondria-Targeted Photodynamic Therapy

Mitochondria-Targeted Polydopamine Nanocomposite with AIE Photosensitizer for Image-Guided Photodynamic and Photothermal Tumor Ablation

A Mitochondria‐Targeted Photosensitizer Showing Improved Photodynamic Therapy Effects under Hypoxia

Cyclometalated iridium(iii) N-heterocyclic carbene complexes as potential mitochondrial anticancer and photodynamic agents.

Biotin-modified Cyclometalated Iridium-Based Photosensitizers As Mitochondria-Targeted Theranostic Agents for Tumor Photodynamic Therapy in Vitro and in Vivo

Cyclometalated Iridium(III) Complexes as High-Sensitivity Two-Photon Excited Mitochondria Dyes and Near-Infrared Photodynamic Therapy Agents

Electrostatic Self-Assembled Iridium(III) Nano-Photosensitizer for Selectively Disintegrated and Mitochondria Targeted Photodynamic Therapy

Aggregation-induced emission-active iridium (III)-based mitochondria-targeting nanoparticle for two-photon imaging-guided photodynamic therapy

Mitochondria-localized Iridium(iii) Complexes with Anthraquinone Groups As Effective Photosensitizers for Photodynamic Therapy under Hypoxia

A Mitochondria-Targeted Zinc(Ii) Phthalocyanine for Photodynamic Therapy